Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 26;12(6):1323.
doi: 10.3390/diagnostics12061323.

Imaging Features of Post Main Hepatectomy Complications: The Radiologist Challenging

Affiliations
Review

Imaging Features of Post Main Hepatectomy Complications: The Radiologist Challenging

Carmen Cutolo et al. Diagnostics (Basel). .

Abstract

In the recent years, the number of liver resections has seen an impressive growth. Usually, hepatic resections remain the treatment of various liver diseases, such as malignant tumors, benign tumors, hydatid disease, and abscesses. Despite technical advancements and tremendous experience in the field of liver resection of specialized centers, there are moderately high rates of postoperative morbidity and mortality, especially in high-risk and older patient populations. Although ultrasonography is usually the first-line imaging examination for postoperative complications, Computed Tomography (CT) is the imaging tool of choice in emergency settings due to its capability to assess the whole body in a few seconds and detect all possible complications. Magnetic resonance cholangiopancreatography (MRCP) is the imaging modality of choice for delineating early postoperative bile duct injuries and ischemic cholangitis that may arise in the late postoperative phase. Moreover, both MDCT and MRCP can precisely detect tumor recurrence. Consequently, radiologists should have knowledge of these surgical procedures for better comprehension of postoperative changes and recognition of the radiological features of various postoperative complications.

Keywords: hepatectomy; postoperative complications; radiologists.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to disclose. The authors confirm that the article is not under consideration for publication elsewhere.

Figures

Figure 1
Figure 1
Postsurgical biloma assessed with MRI at 1 week post resection of VIII segment for liver metastasis. The biloma (arrow) appears hyperintense in T2 (A,B) sequences of MRI study.
Figure 2
Figure 2
Hepatic abscess in resected cholangiocarcinoma on VI hepatic segment, evaluated with MRI. Arrow shows air artifacts within the collection and hyperenhancement of hepatic parenchymal in arterial phase (A) of contrast study that disappears in portal (B) and hepatobiliary (C) phase of contrast study.
Figure 3
Figure 3
Hepatic abscess in resected hepatocellular carcinoma on VI hepatic segment, evaluated with CT. Arrow shows air artifacts within the collection in arterial (A) and portal (B) phase of contrast study.
Figure 4
Figure 4
CT-guided hepatic infected biloma drainage (arrows) and postprocedure assessment in portal phase of contrast study in axial (A) and coronal (B) plane.
Figure 5
Figure 5
Active bleeding (arrow) during arterial (A), portal (B), and late (C) phase of contrast study. In (D), arrow shows contrast collection in perihepatic space.
Figure 6
Figure 6
CT portal phase assessment in resected liver metastases patient. The arrow shows (A,B) mild portal thrombosis.
Figure 7
Figure 7
Bile leaks assessed with MRI T2-W sequence (A) and hepatospecific phase of contrast study (B). Arrow shows leak.
Figure 8
Figure 8
CT assessment in colorectal metastasis-resected patient (A). In (B), arrow shows a new lesion.
Figure 9
Figure 9
Patient with hepatosarcoma evaluated with MRI study ((A): T2-W sequence and (B): portal phase of contrast study). At MRI 6-month evaluation of arterial phase (C) and cholangiography (D) sequences show biliary strictures (arrow).

Similar articles

Cited by

  • A Narrative Review on LI-RADS Algorithm in Liver Tumors: Prospects and Pitfalls.
    De Muzio F, Grassi F, Dell'Aversana F, Fusco R, Danti G, Flammia F, Chiti G, Valeri T, Agostini A, Palumbo P, Bruno F, Cutolo C, Grassi R, Simonetti I, Giovagnoni A, Miele V, Barile A, Granata V. De Muzio F, et al. Diagnostics (Basel). 2022 Jul 7;12(7):1655. doi: 10.3390/diagnostics12071655. Diagnostics (Basel). 2022. PMID: 35885561 Free PMC article. Review.
  • Imaging Features of Main Hepatic Resections: The Radiologist Challenging.
    Cutolo C, Fusco R, Simonetti I, De Muzio F, Grassi F, Trovato P, Palumbo P, Bruno F, Maggialetti N, Borgheresi A, Bruno A, Chiti G, Bicci E, Brunese MC, Giovagnoni A, Miele V, Barile A, Izzo F, Granata V. Cutolo C, et al. J Pers Med. 2023 Jan 10;13(1):134. doi: 10.3390/jpm13010134. J Pers Med. 2023. PMID: 36675795 Free PMC article. Review.
  • Diagnostic Value of Postsurgical Endoscopy.
    Kamaleddine I, Popova M, Alwali A, Schafmayer C. Kamaleddine I, et al. Visc Med. 2025 Apr 1:1-10. doi: 10.1159/000545531. Online ahead of print. Visc Med. 2025. PMID: 40342518 Free PMC article. Review.

References

    1. Lafaro K.J., Stewart C., Fong A., Fong Y. Robotic Liver Resection. Surg. Clin. N. Am. 2020;100:265–281. doi: 10.1016/j.suc.2019.11.003. - DOI - PubMed
    1. Agarwal V., Divatia J.V. Enhanced recovery after surgery in liver resection: Current concepts and controversies. Korean J. Anesthesiol. 2019;72:119–129. doi: 10.4097/kja.d.19.00010. - DOI - PMC - PubMed
    1. Izzo F., Granata V., Grassi R., Fusco R., Palaia R., Delrio P., Carrafiello G., Azoulay D., Petrillo A., Curley S.A. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update. Oncologist. 2019;24:e990–e1005. doi: 10.1634/theoncologist.2018-0337. - DOI - PMC - PubMed
    1. Granata V., Grassi R., Fusco R., Setola S.V., Belli A., Ottaiano A., Nasti G., La Porta M., Danti G., Cappabianca S., et al. Intrahepatic cholangiocarcinoma and its differential diagnosis at MRI: How radiologist should assess MR features. Radiol. Med. 2021;126:1584–1600. doi: 10.1007/s11547-021-01428-7. - DOI - PubMed
    1. Hussein M.A.M., Cafarelli F.P., Paparella M.T., Rennie W.J., Guglielmi G. Phosphaturic mesenchymal tumors: Radiological aspects and suggested imaging pathway. Radiol. Med. 2021;126:1609–1618. doi: 10.1007/s11547-021-01412-1. - DOI - PMC - PubMed

LinkOut - more resources